Gene · 2865
Papers2,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neurotrophic effects of intermittent fasting, calorie restriction and exercise: a review and annotated bibliography. | Front Aging | 2023 | 37334045 | PubTator, text mining | PubMed |
| Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time? | Front Pharmacol | 2023 | 37324466 | PubTator, text mining | PubMed |
| Characteristic Gut Bacteria in High Barley Consuming Japanese Individuals without Hypertension. | Microorganisms | 2023 | 37317220 | PubTator, text mining | PubMed |
| Association between Intestinal Microecological Changes and Atherothrombosis. | Microorganisms | 2023 | 37317197 | PubTator, text mining | PubMed |
| Insights into Antimicrobial and Anti-Inflammatory Applications of Plant Bioactive Compounds. | Microorganisms | 2023 | 37317131 | PubTator, text mining | PubMed |
| Gut microbiome influences incidence and outcomes of breast cancer by regulating levels and activity of steroid hormones in women. | Cancer Rep (Hoboken) | 2023 | 37311575 | PubTator, text mining | PubMed |
| Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity. | Front Immunol | 2023 | 37304266 | PubTator, text mining | PubMed |
| Exploring the Impact of Cyanidin-3-Glucoside on Inflammatory Bowel Diseases: Investigating New Mechanisms for Emerging Interventions. | Int J Mol Sci | 2023 | 37298350 | PubTator, text mining | PubMed |
| Gut Microbiota and Microbial Metabolism in Early Risk of Cardiometabolic Disease. | Circ Res | 2023 | 37289901 | PubTator, text mining | PubMed |
| FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB. | Cell Biosci | 2023 | 37287005 | PubTator, text mining | PubMed |
| Mechanism of immune attack in the progression of obesity-related type 2 diabetes. | World J Diabetes | 2023 | 37273249 | PubTator, text mining | PubMed |
| The impact of microbially modified metabolites associated with obesity and bariatric surgery on antitumor immunity. | Front Immunol | 2023 | 37266441 | PubTator, text mining | PubMed |
| Butyrate inhibits Staphylococcus aureus-aggravated dermal IL-33 expression and skin inflammation through histone deacetylase inhibition. | Front Immunol | 2023 | 37261337 | PubTator, text mining | PubMed |
| Exogenous Ketosis Improves Sleep Efficiency and Counteracts the Decline in REM Sleep after Strenuous Exercise. | Med Sci Sports Exerc | 2023 | 37259248 | PubTator, text mining | PubMed |
| Study of the Relationship between Mucosal Immunity and Commensal Microbiota: A Bibliometric Analysis. | Nutrients | 2023 | 37242281 | PubTator, text mining | PubMed |
| Acute Effects of Dietary Fiber in Starchy Foods on Glycemic and Insulinemic Responses: A Systematic Review of Randomized Controlled Crossover Trials. | Nutrients | 2023 | 37242267 | PubTator, text mining | PubMed |
| Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review. | Nutrients | 2023 | 37242159 | PubTator, text mining | PubMed |
| Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship. | Int J Mol Sci | 2023 | 37240434 | PubTator, text mining | PubMed |
| Intestinal Enteroendocrine Cells: Present and Future Druggable Targets. | Int J Mol Sci | 2023 | 37240181 | PubTator, text mining | PubMed |
| The Role of Adipokines in Health and Disease. | Biomedicines | 2023 | 37238961 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2865/papers?page=19